word count: 176] Background: This was a multi-service evaluation of the clinical and organisational effectiveness of large group psychoeducational CBT delivered within a stepped care model. Method: Clinical outcomes for 4,451 participants in 163 psychoeducational groups delivered across 5 services were analysed by calculating pre-post treatment anxiety (GAD-7) effect sizes (Cohen's d). Overall and betweenservice effects were compared to published efficacy benchmarks. Multilevel modelling was used to examine if variability in clinical outcomes was explained by differences in service, group and patient-level (case-mix) variables.
Introduction
In the United Kingdom, low intensity guided self-help cognitive behavioural interventions are a key feature of services within the Improving Access to Psychological Therapies (IAPT) programme (Clark, 2011) . A commonly available low intensity treatment is the Stress Control (SC) programme (White & Keenan, 1990 ) delivered as an entry-level support option within stepped care IAPT service models. SC is a group-based didactic intervention that teaches anxiety and depression coping skills; it is delivered as a series of 6 lecture-style sessions based on principles of cognitive behavioural therapy (CBT). The content of SC is similar to other CBT-based self-help interventions (see Bennett-Levy, Richards, Farrand, & Christensen, 2010; White, 2008) . The organisationally distinctive features of SC, however, include the delivery to large groups of participants (up to 100 in some services) in a 'night-class' style approach, which emphasises the lack of need for interaction with fellow attendees or facilitators. The high ratio of participants to facilitators makes SC an organisationally efficient treatment option for publically funded services required to treat large clinical populations (Kellett et al., 2007) .
CBT has a robust evidence-base for the treatment of anxiety and depression problems (e.g., see Cuijpers et al., 2013; Hofmann & Smits, 2008) . However, the high prevalence of these common mental health problems, coupled with the low availability and high cost of specialised psychotherapeutic treatments pose challenges to the accessibility of CBT in routine care (National Institute for Health and Care Excellence [NICE], 2011) . In this regard, evidence-based high volume and low cost treatment options like SC could potentially help to meet the high demand for M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 depression and anxiety treatment in general primary care settings. The effectiveness of SC is supported by evidence from one controlled trial (White, Keenan, & Brooks, 1992) , as well as a wide number of practice-based studies reviewed by Burns, Kellett and Donohoe (2016) . Practice-based evidence suggests that SC participants on average experience a 50% reduction in anxiety and depression (Joice & Mercer, 2010; Wood, Kitchiner, & Bisson, 2005) , although such studies do not include control group comparisons. In the most recent practice-based evaluation, Burns et al.
(2016) reported a post-treatment recovery rate of 37% for SC participants and a dose-response relationship between the number of sessions attended and the likelihood of improvement.
Despite the growing evidence-base for SC, no multi-service studies have been conducted to date. The evidence base for SC is grounded in (often small) single-site studies, which have not enabled any cross-service comparisons. Therefore, important questions remain about the generalisability of treatment effects across organisations and teams, as well as the extent to which patient, clinician and group factors may explain the variability in clinical outcomes. Evidence from multi-service studies is necessary to assess the consistency of organisation, delivery, quality and outcomes of psychological healthcare (Weinberger et al., 2001) . Multi-service studies are advantageous as they can provide large, diverse and externallyvalid samples with sufficient statistical power to explore such questions (Gold & Dewa, 2005) . This study sought to conduct the first multi-service 
Method

Design and setting
This study was based on the analysis of historical routine practice data collected by 5 psychological therapy services linked to the Northern IAPT Practice Research Network (see Lucock et al., submitted) . These services follow a stepped care model of treatment delivery (Clark et al., 2009; NICE, 2011) . In this model, step 1 usually involves contact with a general medical practitioner (for assessment and consideration of options including pharmacological and psychological treatment), although some patients Available clinical pathway (treatments received), demographic and outcomes data (described below) were aggregated for all cases that accessed these services and were discharged from treatment between January 2013 and January 2015. Clinical collaborators at each service completed structured qualitative questionnaires to gather information on the delivery of SC 
Measures and data sources
Clinical outcome measures
IAPT services are required to collect standardised patient-reported outcome measures on a session-to-session basis to monitor clinical progress. The GAD-7 is a seven-item measure developed to screen for anxiety disorders (Spitzer, Kroenke, Williams, & Löwe, 2006) . Each item is rated on a 0 to 3 scale, yielding a total anxiety severity score between 0-21. A cut-off score ≥8 is recommended to identify the likely presence of a diagnosable anxiety disorder (Kroenke, Spitzer, Williams, Monahan, & Löwe, 2007) . A change of ≥5 points defines reliable change on the GAD-7 (Richards & Borglin, 2011) . The GAD-7 was the primary outcome measure in this study, given the focus of stress control interventions. The PHQ-9 is a nine-item screening tool for major depression (Kroenke, Spitzer, & Williams, 
defines reliable change on the PHQ-9 (Richards & Borglin, 2011) . The Work and Social Adjustment Scale (WSAS) is a measure of functioning across five domains: work, home management, social leisure activities, private leisure activities, family and close relationships (Mundt, Marks, Shear, & Greist, 2002) . Each item is rated on a scale of 0 (no impairment) to 8 (very severe impairment), rendering a total functional impairment score between 0-40, with no specific change (cut-off) parameter.
Secondary data
Clinical pathway data included information on treatments received (at steps 2 and 3 of the stepped care pathway), number of sessions attended and caseload variables which enabled the matching of each case to a specific SC group and a specific IAPT service. Demographic (age, gender, ethnicity, employment status, socioeconomic deprivation) and clinical characteristics (primary diagnosis, baseline severity in PHQ-9, GAD-7 and WSAS measures at assessment) were available for each case. Socioeconomic deprivation was derived by matching each patient's home postcode to the English Index of Multiple Deprivation (Department for Communities and Local Government, 2011), and categorising cases into quintile levels of deprivation (informed by Paddison et al., 2012) . Three services made very minor modifications to content (e.g. number of power-point slides, terminology used). One service (service 'E') made substantial modifications to SC contents (e.g. reduced length of information, removed explanation of different anxiety disorders and information on relaxation skills) and abridged these into a shortened 5-session intervention.
Stress Control interventions: fidelity, delivery and organisation
Modifications to contents and materials resulted in some differences in the length of sessions between services (ranging between 90-120 minutes). All services delivered SC in clinical (health centres) and community (public seminar and lecture rooms) venues and provided printed materials. Most services (4/5) allowed SC participants to be accompanied by friends or family if necessary. In all services SC was co-facilitated by 2 practitioners. SC facilitators were primarily psychological wellbeing practitioners, but 2 services also included other facilitators (nurses and psychological therapists). Inclusion criteria were generally broad and unrestrictive, although some services applied exclusions for people with severe depression/anxiety, dependent substance use, or diagnoses including OCD, social phobia and PTSD. All services had standard screening procedures to identify cases suitable for treatment in Primary Care, and 3 services enabled participants to self-book onto SC with minimal screening.
Participant characteristics and stepped care pathway
More than half of SC participants were female (63.1%), with a mean age of 42.94 (SD = 13.98; range: 16 -89), and of White British ethnic background (92.6%). Most self-referred (71.4%), with the remainder referred by GPs (21.1%) or other professionals (7.5%). The most common primary presenting problems were mixed anxiety and depression (60.8%), GAD (19.7%) and depressive episode (11.1%). Mean baseline severity scores for the whole cohort were GAD-7 = 11.87 (SD = 5.33), PHQ-9 = 12.13 (SD = 6.02), WSAS = 14.82 (SD = 8.84). The mean number of group sessions attended was 4.26 (SD = 1.65; range = 1 -9). Based on prior research on low intensity interventions (Burns et al., 2016; Delgadillo et al., 2014; Firth, Barkham, Kellett, & Saxon, 2015) , we applied a cut-off (≥4 sessions) to differentiate between SC completers and those who dropped out before receiving an adequate dose of SC. The treatment completion rate for SC was in the region of 70%. Approximately 15% accessed further treatment on completion of SC at steps 2 and 3, or were signposted to other services.
Data analysis 2.5.1. Benchmarking of clinical outcomes
Pre-post treatment effect sizes on the outcome measures for SC interventions (both in the whole sample and for each service) were calculated
with confidence intervals and critical values based on the equations proposed by Minami et al. (2008) . Taking GAD-7 as the primary outcome measure (given the main focus on anxiety management in SC), betweenservice differences in effect sizes were compared using a forest plot and ANOVA. Effect sizes were compared to two benchmarks (pre-post Cohen's d);
one benchmark derived from the only controlled trial of SC (White, Keenan, & Brooks, 1992) and the second benchmark derived from a meta-analysis of 
Dose-response analysis
Reliable and clinically significant improvement (RCSI) criteria (Jacobson & Truax, 1991) were applied to PHQ-9 and GAD-7 outcomes for each participant. To meet RCSI criteria, a patient with baseline scores in the symptomatic range (GAD-7 ≥ 8) should have sub-threshold post-treatment scores (GAD-7 < 8) and a pre-post change score greater than the reliable change index (reduction of at least 5 points in GAD-7). RCSI rates were then calculated for different clusters of participants attending the same number of SC sessions. This procedure enabled a bar chart to be plotted of RCSI rates for clusters of cases with the same SC treatment length, as well cumulative dose-response curves for each symptom measure.
Analysis of case-mix and group effects
Multilevel modelling (MLM) was applied to investigate whether SC outcomes were influenced by patient characteristics (case-mix), after controlling for differences between services and clustering within groups (group effects). Patients (level 1) were nested within SC groups (level 2) and
groups were nested within the 5 services (level 3). The post-treatment GAD-7 score was the independent variable, group was treated as a random effect and service was treated as a fixed effect. Service was treated as a fixed factor, because the small number of services precluded treating them as if they were randomly sampled from the wider population of IAPT services.
Continuous variables were grand mean centred so coefficients can be interpreted in relation to the mean. This analysis was restricted to a subsample where each SC group had at least 5 participants (Total = 4,220 cases nested within 161 groups).
MLM was conducted in 4 steps. Model 1 was an unconditional model without any predictors other than the random effect for SC groups. Model 2 included fixed effects for the number of SC sessions attended and group size as a level-2 variable (i.e. an explanatory variable at group level). Model 3 added services as fixed effects in addition to model 2 variables. Finally, model 4 included fixed effects for case-mix variables: age, gender, ethnicity, employment status (employed vs. unemployed), index of multiple deprivation (IMD) quintile, baseline severity of symptoms (GAD-7, PHQ-9) and functional impairment (WSAS). This enabled the relative influence of group, service, and case-mix factors to be modelled. Goodness-of-fit for all models was assessed based on the Akaike information criterion (AIC), Bayesian information criterion (BIC) and -2 log likelihood statistics, and we tested if adding polynomial terms for continuous variables (sessions, age) improved model fit. An intra-class correlation coefficient (ICC) assessed the overall proportion of variance in GAD-7 outcomes attributable to the group level in each model (Raudenbush, 1993) .
Results
[Figure 2]
Benchmarking of clinical effect sizes across services
Pre-post treatment effect sizes (Cohen's d) for the full sample were GAD-7 = 0.70 (95% CI: 0.66 to 0.73); PHQ-9 = 0.59 (95% CI: 0.56 to 0.62); WSAS = 0.47 (95% CI: 0.44 to 0.50). Effect sizes for cases that dropped out before receiving an adequate dose (attended <4 SC sessions) were considerably smaller (effect size range = 0.20 to 0.31). Figure 2 shows a forest plot of (GAD-7) pre-post effect sizes (and 95% confidence intervals with critical values) for each service, where the size of squares denotes differences in sample size, and the diamond shape represents the pooled effect size for all services. Four services had comparable effect sizes and this was not significantly different to the guided self-help efficacy benchmark (solid vertical line). The exception was in one service (service 'E') which had a significantly smaller effect size compared to other services, plus both benchmarks; F (4, 2933) = 4.29, p < 0.01. The pooled pre-post effect size for all services was significantly greater than the SC efficacy benchmark (dashed vertical line).
[ Figure 3 ]
Clinical outcomes and attendance
On average, 41.6% of cases that initially scored in the clinical range (including completers and dropouts) met RCSI criteria by their last attended SC session (GAD-7 = 42.2%; PHQ-9 = 41.0%). were for those cases attending between 4-6 sessions. The curves superimposed onto the figure offer a visual representation of the cumulative percentage of cases that met RCSI criteria.
[ Table 1] 3.3. Multilevel modelling of service, group and patient variables A stepwise approach to multilevel modelling (MLM) was taken, as illustrated in Table 1 . Model 1 with no covariates (i.e. variance components model) had a significant random effect estimate (Z = 36.841, p <.001), with an ICC value suggesting that 3.6% of variance in post-treatment anxiety scores was explained by variability between SC groups. On this basis, it was appropriate to account for the nested structure of the data in further analyses.
Model 2 (including covariates) suggested a curvilinear relationship (the sessions variable and its quadratic term were both significant predictors, p <.001) between the number of group sessions attended and post-treatment outcomes. This non-linear relationship is consistent with the dose-response curve in Figure 3 . Group size (number of participants in each SC class) did not predict post-treatment anxiety scores (β = 0.005, SE = 0.005, p = .374).
Model 3 included services as covariates, confirming that services B (β = -1.567, SE = 0.419, p < .001) and D (β = -2.133, SE = 0.480, p < .001) tended to have lower post-treatment anxiety scores (better outcomes) compared to service E (which was the reference category).
Model 4 additionally included case-mix variables, confirming that higher post-treatment anxiety scores were found for cases in the most M A N U S C R I P T
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14 socioeconomically deprived areas (IMD quintile 1, β = 0.720, SE = 0.338, p = .034) and those with higher baseline GAD-7 (β = 0.475, SE = 0.027, p < .001), PHQ-9 (β = 0.154, SE = 0.025, p < .001) and WSAS scores (β = 0.031, SE = 0.013, p = .020). Age, gender, ethnicity and employment status were not found to be statistically significant in this model (all had p < .05).
Importantly, the service variable was no longer statistically significant (F (4, 1,842) = 0.993, p = .410) in model 4, suggesting that differences between services were fully explained by differences in group and case-mix variables. Although the SC treatment effects were fairly consistent across most services, there was evidence that one of the five participating services (service E) attained lower effect sizes which were in the moderate range (GAD-7 d = 0.48). SC delivered at this service deviated from the standard treatment protocol, with psychoeducational materials condensed into a shortened 5-session group programme. Compared to other participating services, patients at this service were more socioeconomically disadvantaged and had higher levels of symptom severity and functional impairment. An adequately powered multilevel modelling analysis demonstrated that outcome differences between services were largely explained by these differences in therapy length and case-mix variables. concluded that the effectiveness of low intensity interventions is maximised between 4 to 6 sessions; additional sessions after this point rarely lead to better outcomes (Delgadillo et al., 2014; Firth et al., 2015) . In fact, Burns et al. (2016) found that SC patients who had additional concurrent treatment at step 2 (low intensity) did not attain superior outcomes to those who simply attended SC. Our dose-response analysis adds further evidence for this 'optimal dose of psychoeducation' pattern. Previous studies have also demonstrated that patient-factors such as higher baseline severity of depression, severe functional impairment, socioeconomic poverty and unemployment predict poorer outcomes in low intensity psychological interventions (Delgadillo, Asaria, Ali, & Gilbody, in press; Delgadillo, Moreea, & Lutz, 2016; Firth et al., 2015) .
To our knowledge, this is the first study to investigate the extent to which psychoeducation outcomes are influenced by differences between groups (e.g., group effects). Differences between groups were found to explain up to 3.6% of variance in post-treatment outcomes. This estimate is smaller by comparison to the general influence of therapist effects in formal 'high intensity' psychotherapy (between 5% and 10%; Baldwin & Imel, 2013), but closer to those of low intensity interventions delivered in IAPT services (between 1% and 9%; Ali et al., 2014; Green et al., 2014; Firth et al., 2015) .
Though the group estimate is small, it is remarkable that a highly standardised and manualised psychoeducational intervention with minimal therapist-patient interaction should yield between-group differences. It is plausible that variability in facilitators' competence and delivery may partly explain these group effects (Burlingame, Strauss, & Joyce, 2013) . In this regard, future research could focus on the development of methods to measure and to enhance facilitator competency. It is also possible that other M A N U S C R I P T
18 factors related to the group context (e.g., self-referral versus professional referral, accessibility of venues, the extent to which the atmosphere is perceived as welcoming and non-threatening) may play into group effects, though further research is necessary to verify this.
This study explored the potential influence of one such contextual variable: group size, which was not associated with clinical effects. Patients in SC groups as large as 100 participants were equally likely to benefit from the intervention as those in smaller groups. The size of SC groups may have a normalising effect for participants and further research on SC mechanisms of change is needed. The finding regarding group size strengthens the argument that high volume SC classes are likely to be an organisationally efficient treatment option. The clinical caveat to this assertion, however, is that some patients with particular characteristics are much less likely to benefit from SC and tend to drop out of care early on. We also noted that effect sizes for PHQ-9 (d = .59) and WSAS (d = .47) were more modest compared to those for anxiety outcomes measured using GAD-7 (d = .70).
This suggests that patients with more severe depression and functional impairment derive less benefit from SC interventions; which is consistent with prior outcome-prediction studies of low intensity interventions (Delgadillo et al., 2016) .
Limitations
The pre-post treatment effect sizes described in this study offer a general estimate of the 'real world' effectiveness of SC interventions delivered in routine stepped care services. As a naturalistic cohort study, these effect sizes are not assessed relative to control groups, and therefore it is possible that regression to the mean (i.e., natural fluctuations in mental health M A N U S C R I P T
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19 symptoms due to the passage of time) may have partly accounted for some of the reported effects. Furthermore, our uncontrolled data do not allow us to disentangle specific SC treatment effects from effects that may be due to general contact with healthcare practitioners and other patients in a groupbased setting. The small number of services clustered in Northern England may not necessarily be representative of populations in other regions of the country or internationally, so further replication in other regions would help to establish the generalisability of SC effects with greater certainty. Although we were able to link individual patients to specific SC groups, the available data did not enable us to match groups to pairs of facilitators. Therefore, it was not possible to examine the influence of specific facilitators, who may possibly vary in fidelity, competence and credibility. Standardised SC fidelity measures or checklists were not available or routinely collected in these services, so we relied on self-reported qualitative data to determine the extent to which SC treatments were standardised across services.
Furthermore, an important limitation of this study is that we were only able to examine short-term outcomes, since post-treatment follow-up data were not available. Research on the durability of clinical effects over longer followup periods is necessary to support the evidence-base for large group psychoeducation.
Clinical implications
We propose five key points that may maximise the effectiveness of SC 
Conclusions
This study has illustrated that large group psychoeducational CBT is Notes: All continuous variables are mean centred; ICC = intra-class correlation coefficient; β = fixed coefficients; SE = standard error; CI = confidence intervals; AIC = Aikake (corrected) information criterion; BIC = Bayesian information criterion; sessions 2 = quadratic term for sessions attended; * Z-tests for all variance estimates were significant at p <.01; **service = 5-level variable with service E as the reference category; ***IMD = 5-level variable representing quintiles of socioeconomic deprivation with quintile 5 (least deprived) as reference category; non-significant fixed effects are excluded from the table (stress control group 
